KIMCO logo

KIMCO

Asia, Seoul-t'ukpyolsi, South Korea, Seocho

Description

KIMCO(The Korea Innovative Medicines Consortium) is a collaboration platform for pharmaceutical and biotechnology companies.

Investor Profile

KIMCO has made 2 investments, with 1 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (50%)
  • Series C (50%)

Country Focus

  • United States (50%)
  • South Korea (50%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Genetics
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does KIMCO frequently co-invest with?

Dong-A ST
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
PP
North America, Michigan, United States, Rochester Hills
Co-Investments: 1
Korea Development Bank
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Mirae Asset Venture Investment
Asia, Kyonggi-do, South Korea, Seongnam
Co-Investments: 1
Terra VC
Asia, Dubai, United Arab Emirates, Dubai
Co-Investments: 1
Huons
Asia, Kyonggi-do, South Korea, Seongnam
Co-Investments: 1
loftyrock investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
A
North America, New York, United States, New York
Co-Investments: 1
K2 Investment Partners
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1

What are some of recent deals done by KIMCO?

Inventera Pharmaceuticals

Seocho, Seoul-t'ukpyolsi, South Korea

Inventera Pharmaceutical is a biotechnology company that specializes in the development of imaging diagnostic contrast agents.

BiotechnologyPharmaceutical
Series COct 30, 2024
Amount Raised: $13,428,092
GenEdit

South San Francisco, California, United States

GenEdit develops next generation therapeutics for genetic diseases through safe and efficient CRISPR/Cas9 delivery.

BiotechnologyGeneticsPharmaceuticalTherapeutics
Series AJan 23, 2024
Amount Raised: $24,000,000